Log in to save to my catalogue
Log in to save to my catalogue

Adalimumab and etanercept serum (anti)drug levels are not predictive for successful dose reduction o...

| Ask | Become a Library member

Adalimumab and etanercept serum (anti)drug levels are not predictive for successful dose reduction o...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_510908

Adalimumab and etanercept serum (anti)drug levels are not predictive for successful dose reduction or discontinuation in rheumatoid arthritis

About this item

Full title

Adalimumab and etanercept serum (anti)drug levels are not predictive for successful dose reduction or discontinuation in rheumatoid arthritis

Author / Creator

van Herwaarden, Noortje , Bouman, Chantal A M , van der Maas, Aatke , van Vollenhoven, Ronald F , Bijlsma, Johannes W , van den Hoogen, Frank H J , den Broeder, Alfons A and van den Bemt, Bart J F

Publisher

England: Elsevier Limited

Journal title

Annals of the rheumatic diseases, 2015-12, Vol.74 (12), p.2260-2261

Language

English

Formats

Articles

Publication information

Publisher

England: Elsevier Limited

Subjects

More information

Alternative Titles

Full title

Adalimumab and etanercept serum (anti)drug levels are not predictive for successful dose reduction or discontinuation in rheumatoid arthritis

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_swepub_ki_se_510908

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_510908

Other Identifiers

ISSN

0003-4967

E-ISSN

1468-2060

DOI

10.1136/annrheumdis-2015-207814

How to access this item

Log in as a Library member

Full text available

About resource

About resource

View in old catalogue

Connecting people and collections